Clinical-stage pharma stock Theralase Technologies (TSXV:TLT) announced a significant breakthrough in the treatment of Herpes ...

The World Health Organization (WHO) recently released new estimates suggesting around 846 million people aged between 15 and 49 live with a genital herpes infection. That's equivalent to one in every ...

University of Manitoba independent research verifies that RuvidarTM is more effective than acyclovir in the inactivation of Herpes Simplex Viruses post infection. TORONTO, ON / ACCESS Newswire / ...

Genital herpes simplex virus (HSV) infections are frequently asymptomatic or undiagnosed, but more than half the US population is seropositive for HSV, and about one-fifth are positive for HSV-2.

Several promising alternative strategies have emerged for control of HSV infections, including immunoprophylaxis, immunotherapy and mucosal vaccination. The ocular, genital tract and oral–facial ...

In a human cell-based brain model, repetitive physical injuries reactivate the common virus, Herpes Simplex Virus 1 (HSV-1), ...

Herpes simplex virus type 2 (HSV-2) is a type of herpes virus. HSV-2 transmission through oral sex alone is rare, though it is possible to acquire the virus through sexual contact. HSV-2 causes ...

The World Health Organization (WHO) recently released new estimates suggesting around 846 million people aged between 15 and 49 live with a genital herpes infection. That's equivalent to one in ...

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond ...